News
LJUIF
0.540
NaN%
--
SSY Group Expands Restricted Share Award Pool with Market Purchase
TipRanks · 5d ago
SSY Group Buys Back 1 Million Shares for Restricted Award Scheme
TipRanks · 6d ago
SSY Group Boosts Share Award Pool with Open-Market Purchase
TipRanks · 06/24 09:39
SSY Group Buys Back 2 Million Shares for Employee Award Scheme
TipRanks · 06/23 09:11
SSY Group Wins NMPA Approvals for Parkinson’s and Respiratory Drugs
TipRanks · 06/22 04:07
SSY Group Adds Shares to Restricted Award Scheme via Market Purchase
TipRanks · 06/17 09:13
SSY Group Expands Pool of Shares for Restricted Award Scheme via Market Purchase
TipRanks · 06/16 09:09
SSY Group Wins China Approval for New Cefpodoxime Suspension
TipRanks · 06/16 00:37
SSY Group Boosts Restricted Share Award Holdings With HK$2.28 Million Share Purchase
TipRanks · 06/15 09:09
SSY Group Secures Exclusive China Rights to Innovative Peritoneal Dialysis Drug OPT101
TipRanks · 06/15 00:07
SSY Group Boosts Employee Incentive Pool with Open-Market Share Purchase
TipRanks · 06/12 09:46
SSY Group Wins Approval as Marketing Authorization Holder for Key Injectable Antibiotic
TipRanks · 06/08 04:07
SSY Group Moves Into Biosimilars With Longhai Pharma Tie-Up
TipRanks · 06/05 04:08
SSY Group Unit Signs LOI for Two Modified New Drugs in China
TipRanks · 06/04 12:10
SSY Group Wins China Approval for New Hypertension Bulk Drug
TipRanks · 05/21 10:10
SSY Group Wins Series of NMPA Approvals, Expands High-Value Generics Portfolio
TipRanks · 05/21 09:08
SSY Group Wins Strong Shareholder Backing at 2026 AGM
TipRanks · 05/15 09:25
SSY Group Wins Trio of NMPA Approvals, Expanding China Drug Portfolio
TipRanks · 05/11 00:37
SSY Group Wins NMPA Approval for New Vitamin B12 Injection Specification
TipRanks · 05/07 08:40
SSY Group Wins Hebei Approval for New Inflammation and Cardiovascular Diagnostic Test Kits
TipRanks · 05/06 09:11
More
Webull provides a variety of real-time LJUIF stock news. You can receive the latest news about Ssy Group through multiple platforms. This information may help you make smarter investment decisions.
About LJUIF
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.